Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Endovascular versus medical therapy for large-vessel anterior occlusive stroke presenting with mild symptoms.

Wolman DN, Marcellus DG, Lansberg MG, Albers G, Guenego A, Marks MP, Dodd RL, Do HM, Wintermark M, Martin BW, Heit JJ.

Int J Stroke. 2019 Aug 31:1747493019873510. doi: 10.1177/1747493019873510. [Epub ahead of print]

PMID:
31474193
2.

Thrombectomy for acute ischemic stroke in nonagenarians compared with octogenarians.

Sussman ES, Martin B, Mlynash M, Marks MP, Marcellus D, Albers G, Lansberg M, Dodd R, Do HM, Heit JJ.

J Neurointerv Surg. 2019 Jul 26. pii: neurintsurg-2019-015147. doi: 10.1136/neurintsurg-2019-015147. [Epub ahead of print]

PMID:
31350369
3.

Thrombectomy Results in Reduced Hospital Stay, More Home-Time, and More Favorable Living Situations in DEFUSE 3.

Tate WJ, Polding LC, Kemp S, Mlynash M, Heit JJ, Marks MP, Albers GW, Lansberg MG.

Stroke. 2019 Sep;50(9):2578-2581. doi: 10.1161/STROKEAHA.119.025165. Epub 2019 Jul 10.

PMID:
31288666
4.

Neuroimaging selection for thrombectomy in pediatric stroke: a single-center experience.

Lee S, Heit JJ, Albers GW, Wintermark M, Jiang B, Bernier E, Fischbein NJ, Mlynash M, Marks MP, Do HM, Dodd RL.

J Neurointerv Surg. 2019 Sep;11(9):940-946. doi: 10.1136/neurintsurg-2019-014862. Epub 2019 May 16.

PMID:
31097548
5.

Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis.

Powers CJ, Dornbos D 3rd, Mlynash M, Gulati D, Torbey M, Nimjee SM, Lansberg MG, Albers GW, Marks MP.

AJNR Am J Neuroradiol. 2019 Jun;40(6):1001-1005. doi: 10.3174/ajnr.A6059. Epub 2019 May 9.

PMID:
31072970
6.

Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study.

Heit JJ, Mlynash M, Kemp SM, Lansberg MG, Christensen S, Marks MP, Ortega-Gutierrez S, Albers GW.

Stroke. 2019 May;50(5):1172-1177. doi: 10.1161/STROKEAHA.119.024928.

PMID:
30932783
7.

Cerebral foreign body reaction due to hydrophilic polymer embolization following aneurysm treatment by pipeline flow diversion device.

Geisbush TR, Marks MP, Heit JJ.

Interv Neuroradiol. 2019 Aug;25(4):447-453. doi: 10.1177/1591019919830767. Epub 2019 Mar 28.

PMID:
30922199
8.

Hypoperfusion Intensity Ratio Is Correlated With Patient Eligibility for Thrombectomy.

Guenego A, Marcellus DG, Martin BW, Christensen S, Albers GW, Lansberg MG, Marks MP, Wintermark M, Heit JJ.

Stroke. 2019 Apr;50(4):917-922. doi: 10.1161/STROKEAHA.118.024134.

PMID:
30841821
9.

Persistent Target Mismatch Profile >24 Hours After Stroke Onset in DEFUSE 3.

Christensen S, Mlynash M, Kemp S, Yennu A, Heit JJ, Marks MP, Lansberg MG, Albers GW.

Stroke. 2019 Mar;50(3):754-757. doi: 10.1161/STROKEAHA.118.023392.

PMID:
30735466
10.

Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial.

Sarraj A, Mlynash M, Savitz SI, Heit JJ, Lansberg MG, Marks MP, Albers GW.

JAMA Neurol. 2019 Jun 1;76(6):682-689. doi: 10.1001/jamaneurol.2019.0118.

PMID:
30734042
11.

Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3.

Rao V, Christensen S, Yennu A, Mlynash M, Zaharchuk G, Heit J, Marks MP, Lansberg MG, Albers GW.

Stroke. 2019 Mar;50(3):626-631. doi: 10.1161/STROKEAHA.118.023177.

PMID:
30727840
12.

Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome

de Havenon A, Mlynash M, Kim-Tenser MA, Lansberg MG, Leslie-Mazwi T, Christensen S, McTaggart RA, Alexander M, Albers G, Broderick J, Marks MP, Heit JJ; DEFUSE 3 Investigators.

Stroke. 2019 Mar;50(3):632-638. doi: 10.1161/STROKEAHA.118.023407.

PMID:
30726184
13.

Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.

Lansberg MG, Mlynash M, Hamilton S, Yeatts SD, Christensen S, Kemp S, Lavori PW, Ortega-Gutierrez S, Broderick J, Heit J, Marks MP, Albers GW; DEFUSE 3 Investigators.

JAMA Neurol. 2019 Apr 1;76(4):447-453. doi: 10.1001/jamaneurol.2018.4587.

PMID:
30688974
14.

Surgical Treatment of Recurrent Previously Coiled and/or Stent-Coiled Intracerebral Aneurysms: A Single-Center Experience in a Series of 75 Patients.

Liu JJ, Nielsen TH, Abhinav K, Lee J, Han SS, Marks MP, Do HM, Dodd RL, Steinberg GK.

World Neurosurg. 2019 Jan 11. pii: S1878-8750(19)30041-5. doi: 10.1016/j.wneu.2018.12.171. [Epub ahead of print]

PMID:
30639494
15.

Multimodal management of arteriovenous malformations of the basal ganglia and thalamus: factors affecting obliteration and outcome.

Madhugiri VS, Teo MKC, Westbroek EM, Chang SD, Marks MP, Do HM, Levy RP, Steinberg GK.

J Neurosurg. 2018 Aug 17:1-10. doi: 10.3171/2018.2.JNS172511. [Epub ahead of print]

PMID:
30117771
16.

Endovascular Treatment in the DEFUSE 3 Study.

Marks MP, Heit JJ, Lansberg MG, Kemp S, Christensen S, Derdeyn CP, Rasmussen PA, Zaidat OO, Broderick JP, Yeatts SD, Hamilton S, Mlynash M, Albers GW; DEFUSE 3 Investigators.

Stroke. 2018 Aug;49(8):2000-2003. doi: 10.1161/STROKEAHA.118.022147.

17.

Thrombectomy for Stroke with Selection by Perfusion Imaging.

Albers GW, Marks MP, Lansberg MG.

N Engl J Med. 2018 May 10;378(19):1849-1850. doi: 10.1056/NEJMc1803856. No abstract available.

PMID:
29742373
18.

Early Cerebral Vein After Endovascular Ischemic Stroke Treatment Predicts Symptomatic Reperfusion Hemorrhage.

Cartmell SCD, Ball RL, Kaimal R, Telischak NA, Marks MP, Do HM, Dodd RL, Albers GW, Lansberg MG, Heit JJ.

Stroke. 2018 Jul;49(7):1741-1746. doi: 10.1161/STROKEAHA.118.021402. Epub 2018 May 8.

PMID:
29739912
19.

Time From Imaging to Endovascular Reperfusion Predicts Outcome in Acute Stroke.

Tsai JP, Mlynash M, Christensen S, Kemp S, Kim S, Mishra NK, Federau C, Nogueira RG, Jovin TG, Devlin TG, Akhtar N, Yavagal DR, Bammer R, Straka M, Zaharchuk G, Marks MP, Albers GW, Lansberg MG; CRISP Investigators.

Stroke. 2018 Apr;49(4):952-957. doi: 10.1161/STROKEAHA.117.018858. Epub 2018 Mar 16.

20.

Can diffusion- and perfusion-weighted imaging alone accurately triage anterior circulation acute ischemic stroke patients to endovascular therapy?

Wolman DN, Iv M, Wintermark M, Zaharchuk G, Marks MP, Do HM, Dodd RL, Albers GW, Lansberg MG, Heit JJ.

J Neurointerv Surg. 2018 Dec;10(12):1132-1136. doi: 10.1136/neurintsurg-2018-013784. Epub 2018 Mar 19.

PMID:
29555872
21.

Arterial Spin-Labeling Improves Detection of Intracranial Dural Arteriovenous Fistulas with MRI.

Amukotuwa SA, Marks MP, Zaharchuk G, Calamante F, Bammer R, Fischbein N.

AJNR Am J Neuroradiol. 2018 Apr;39(4):669-677. doi: 10.3174/ajnr.A5570. Epub 2018 Mar 15.

22.

Reduced Intravoxel Incoherent Motion Microvascular Perfusion Predicts Delayed Cerebral Ischemia and Vasospasm After Aneurysm Rupture.

Heit JJ, Wintermark M, Martin BW, Zhu G, Marks MP, Zaharchuk G, Dodd RL, Do HM, Steinberg GK, Lansberg MG, Albers GW, Federau C.

Stroke. 2018 Mar;49(3):741-745. doi: 10.1161/STROKEAHA.117.020395. Epub 2018 Feb 9.

PMID:
29439196
23.

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators.

N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24.

24.

A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).

Albers GW, Lansberg MG, Kemp S, Tsai JP, Lavori P, Christensen S, Mlynash M, Kim S, Hamilton S, Yeatts SD, Palesch Y, Bammer R, Broderick J, Marks MP.

Int J Stroke. 2017 Oct;12(8):896-905. doi: 10.1177/1747493017701147. Epub 2017 Mar 24.

25.

Patient Outcomes and Cerebral Infarction after Ruptured Anterior Communicating Artery Aneurysm Treatment.

Heit JJ, Ball RL, Telischak NA, Do HM, Dodd RL, Steinberg GK, Chang SD, Wintermark M, Marks MP.

AJNR Am J Neuroradiol. 2017 Nov;38(11):2119-2125. doi: 10.3174/ajnr.A5355. Epub 2017 Sep 7.

26.

Sofia intermediate catheter and the SNAKE technique: safety and efficacy of the Sofia catheter without guidewire or microcatheter construct.

Heit JJ, Wong JH, Mofaff AM, Telischak NA, Dodd RL, Marks MP, Do HM.

J Neurointerv Surg. 2018 Apr;10(4):401-406. doi: 10.1136/neurintsurg-2017-013256. Epub 2017 Aug 2.

PMID:
28768818
27.

Pipeline embolization device retraction and foreshortening after internal carotid artery blister aneurysm treatment.

Heit JJ, Telischak NA, Do HM, Dodd RL, Steinberg GK, Marks MP.

Interv Neuroradiol. 2017 Dec;23(6):614-619. doi: 10.1177/1591019917722514. Epub 2017 Jul 31.

28.

Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke.

Lansberg MG, Christensen S, Kemp S, Mlynash M, Mishra N, Federau C, Tsai JP, Kim S, Nogueria RG, Jovin T, Devlin TG, Akhtar N, Yavagal DR, Haussen D, Dehkharghani S, Bammer R, Straka M, Zaharchuk G, Marks MP, Albers GW; CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project (CRISP) Investigators.

Ann Neurol. 2017 Jun;81(6):849-856. doi: 10.1002/ana.24953. Epub 2017 Jun 9.

29.

Clot Imaging in Large Vessel Occlusion Strokes.

Wong JH, Marks MP.

Top Magn Reson Imaging. 2017 Jun;26(3):121-125. doi: 10.1097/RMR.0000000000000127. Review.

PMID:
28277464
30.

Embolization Followed by Radiosurgery for the Treatment of Brain Arteriovenous Malformations (AVMs).

Marks MP, Marcellus ML, Santarelli J, Dodd RL, Do HM, Chang SD, Adler JR, Mlynash M, Steinberg GK.

World Neurosurg. 2017 Mar;99:471-476. doi: 10.1016/j.wneu.2016.12.059. Epub 2016 Dec 23.

PMID:
28017742
31.

Initial experience with SOFIA as an intermediate catheter in mechanical thrombectomy for acute ischemic stroke.

Wong JHY, Do HM, Telischak NA, Moraff AM, Dodd RL, Marks MP, Ingle SM, Heit JJ.

J Neurointerv Surg. 2017 Nov;9(11):1103-1106. doi: 10.1136/neurintsurg-2016-012750. Epub 2016 Oct 27.

PMID:
27789787
32.

Surgical outcomes of Majewski osteodysplastic primordial dwarfism Type II with intracranial vascular anomalies.

Teo M, Johnson JN, Bell-Stephens TE, Marks MP, Do HM, Dodd RL, Bober MB, Steinberg GK.

J Neurosurg Pediatr. 2016 Dec;25(6):717-723. Epub 2016 Sep 9.

PMID:
27611897
33.

Pretreatment blood-brain barrier disruption and post-endovascular intracranial hemorrhage.

Leigh R, Christensen S, Campbell BC, Marks MP, Albers GW, Lansberg MG; DEFUSE 2 Investigators.

Neurology. 2016 Jul 19;87(3):263-9. doi: 10.1212/WNL.0000000000002862. Epub 2016 Jun 17.

34.

Detection of Cortical Venous Drainage and Determination of the Borden Type of Dural Arteriovenous Fistula by Means of 3D Pseudocontinuous Arterial Spin-Labeling MRI.

Amukotuwa SA, Heit JJ, Marks MP, Fischbein N, Bammer R.

AJR Am J Roentgenol. 2016 Jul;207(1):163-9. doi: 10.2214/AJR.15.15171. Epub 2016 Apr 15.

PMID:
27082987
35.

Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research Priorities.

Warach SJ, Luby M, Albers GW, Bammer R, Bivard A, Campbell BC, Derdeyn C, Heit JJ, Khatri P, Lansberg MG, Liebeskind DS, Majoie CB, Marks MP, Menon BK, Muir KW, Parsons MW, Vagal A, Yoo AJ, Alexandrov AV, Baron JC, Fiorella DJ, Furlan AJ, Puig J, Schellinger PD, Wintermark M; Stroke Imaging Research (STIR) and VISTA-Imaging Investigators.

Stroke. 2016 May;47(5):1389-98. doi: 10.1161/STROKEAHA.115.012364. Epub 2016 Apr 12.

36.

Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.

McFarland BC, Marks MP, Rowse AL, Fehling SC, Gerigk M, Qin H, Benveniste EN.

Oncotarget. 2016 Apr 12;7(15):20621-35. doi: 10.18632/oncotarget.7992.

37.

Effect of endovascular reperfusion in relation to site of arterial occlusion.

Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, Yeatts SD, Palesch YY, Saver JL, Pereira VM, Broderick JP, Albers GW, Lansberg MG; DEFUSE 2, IMS III, STAR, and SWIFT trialists; DEFUSE 2 IMS III STAR and SWIFT trialists.

Neurology. 2016 Feb 23;86(8):762-70. doi: 10.1212/WNL.0000000000002399. Epub 2016 Jan 22.

38.

Acute Preoperative Infarcts and Poor Cerebrovascular Reserve Are Independent Risk Factors for Severe Ischemic Complications following Direct Extracranial-Intracranial Bypass for Moyamoya Disease.

Antonucci MU, Burns TC, Pulling TM, Rosenberg J, Marks MP, Steinberg GK, Zaharchuk G.

AJNR Am J Neuroradiol. 2016 Feb;37(2):228-235. doi: 10.3174/ajnr.A4535. Epub 2015 Nov 12.

39.

ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway.

Fernández NB, Lorenzo D, Picco ME, Barbero G, Dergan-Dylon LS, Marks MP, García-Rivello H, Gimenez L, Labovsky V, Grumolato L, Lopez-Bergami P.

Mol Carcinog. 2016 Nov;55(11):1772-1785. doi: 10.1002/mc.22426. Epub 2015 Oct 28.

PMID:
26509654
40.

Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue.

Lansberg MG, Cereda CW, Mlynash M, Mishra NK, Inoue M, Kemp S, Christensen S, Straka M, Zaharchuk G, Marks MP, Bammer R, Albers GW; Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 (DEFUSE 2) Study Investigators.

Neurology. 2015 Aug 25;85(8):708-14. doi: 10.1212/WNL.0000000000001853. Epub 2015 Jul 29.

41.

Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma.

Rajbhandari R, McFarland BC, Patel A, Gerigk M, Gray GK, Fehling SC, Bredel M, Berbari NF, Kim H, Marks MP, Meares GP, Sinha T, Chuang J, Benveniste EN, Nozell SE.

Oncotarget. 2015 Jul 10;6(19):17805-16.

42.

Reperfusion of very low cerebral blood volume lesion predicts parenchymal hematoma after endovascular therapy.

Mishra NK, Christensen S, Wouters A, Campbell BC, Straka M, Mlynash M, Kemp S, Cereda CW, Bammer R, Marks MP, Albers GW, Lansberg MG; DEFUSE 2 Investigators.

Stroke. 2015 May;46(5):1245-9. doi: 10.1161/STROKEAHA.114.008171. Epub 2015 Mar 31.

43.

Alberta stroke program early computed tomographic scoring performance in a series of patients undergoing computed tomography and MRI: reader agreement, modality agreement, and outcome prediction.

McTaggart RA, Jovin TG, Lansberg MG, Mlynash M, Jayaraman MV, Choudhri OA, Inoue M, Marks MP, Albers GW; DEFUSE 2 Investigators.

Stroke. 2015 Feb;46(2):407-12. doi: 10.1161/STROKEAHA.114.006564. Epub 2014 Dec 23.

PMID:
25538199
44.

Endovascular treatment of a tentorial dural arteriovenous fistula.

Choudhri O, Marks MP.

Neurosurg Focus. 2014 Jul;37(1 Suppl):1. doi: 10.3171/2014.V2.FOCUS14184.

PMID:
24983732
45.

Endovascular management of cerebral venous sinus thrombosis.

Choudhri O, Feroze A, Marks MP, Do HM.

Neurosurg Focus. 2014 Jul;37(1 Suppl):1. doi: 10.3171/2014.V2.FOCUS14186.

PMID:
24983720
46.

The case for angioplasty in patients with symptomatic intracranial atherosclerosis.

McTaggart RA, Marks MP.

Front Neurol. 2014 Apr 11;5:36. doi: 10.3389/fneur.2014.00036. eCollection 2014. Review.

47.

Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.

McTaggart RA, Choudhri OA, Marcellus ML, Brennan T, Steinberg GK, Dodd RL, Do HM, Marks MP.

J Neurointerv Surg. 2015 Jun;7(6):425-30. doi: 10.1136/neurintsurg-2013-011089. Epub 2014 Apr 16.

PMID:
24739599
48.

Angiographic outcome of endovascular stroke therapy correlated with MR findings, infarct growth, and clinical outcome in the DEFUSE 2 trial.

Marks MP, Lansberg MG, Mlynash M, Kemp S, McTaggart RA, Zaharchuk G, Bammer R, Albers GW; DEFUSE Investigators.

Int J Stroke. 2014 Oct;9(7):860-5. doi: 10.1111/ijs.12271. Epub 2014 Mar 31.

49.

Interhospital variation in reperfusion rates following endovascular treatment for acute ischemic stroke.

Liggins JT, Mlynash M, Jovin TG, Straka M, Kemp S, Bammer R, Marks MP, Albers GW, Lansberg MG; DEFUSE 2 Investigators.

J Neurointerv Surg. 2015 Apr;7(4):231-3. doi: 10.1136/neurintsurg-2014-011115. Epub 2014 Mar 24.

50.

Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort.

Olivot JM, Mlynash M, Inoue M, Marks MP, Wheeler HM, Kemp S, Straka M, Zaharchuk G, Bammer R, Lansberg MG, Albers GW; DEFUSE 2 Investigators.

Stroke. 2014 Apr;45(4):1018-23. doi: 10.1161/STROKEAHA.113.003857. Epub 2014 Mar 4. Erratum in: Stroke. 2014 May;45(5):e92.

Supplemental Content

Loading ...
Support Center